Last week we had the opportunity to host Sonia Guirado, a member of the Eurofirms Foundation and a r...
Viralgen Vector Core, S.L. ha obtenido una vez más apoyo desde el Gobierno Vasco a través del Progra...
Viralgen Vector Core, S.L. ha obtenido una vez más apoyo desde el Gobierno Vasco a través del Progra...
VIRALGEN COMMERCIAL THERAPEUTIC, S.L. has secured vital support from the HAZITEK Business R&D Suppor...
VIRALGEN VECTOR CORE, S.L. has secured vital support from the HAZITEK Business R&D Support Program o...
Viralgen Vector Core and Elpida Therapeutics partner to manufacture gene therapy medicines for antic...
Last week, we participated in the ASGCT 26th Annual Meeting, which was held in Los Angeles.
ASGCT 26th Annual Meeting starts in a few days. This year, it will be held in Los Angeles from May 1...
Rare Disease Day is the globally coordinated movement on rare diseases, working towards equity in so...
Visit us at Phacilitate Advanced Therapies Week in Miami, January 17 – 20, 2023, Booth 425. Hear abo...
